Skip to content

Corporate
- Pitch
- Mission
- CSR
- Team
Technology
Pipeline
Clinical trials
Newsroom
Partnerships

Home
Corporate
- Pitch
- Mission
- CSR
- Team
Technology
Pipeline
Clinical trials
Newsroom
Partnerships
Contact

C

1 min read

[Newsletter-6] NEWS/INFO

Author Bertrand Fabien
Published 16 juin 2020

June 15, 2020.

>> Breaking news / Edition spéciale <<

Download our newsletter (english version)
Télécharger notre newsletter (version française)

Related Posts

Reflections on #AACR2024: our key insights and contributions

April, 2024. The AACR Annual Meeting in San Diego was a pivotal...

XENOTHERA announces the start of the second dose cohort in the FIPO trial

March, 2024. FIPO is the first-in-human trial of XON7, the first anti-solid...

XENOTHERA : publication of the first-in-human trial of LIS1 in Solid Organ Transplantation

February, 2024. For almost ten years, XENOTHERA has been committed to tackling...

Corporate
Technology
Pipeline

Clinical trials
Newsroom
Partnerships

Contact
Legal notice

XENOTHERA

21 rue La Nouë de Fer, 44200 Nantes, France

contact@xenothera.com

Media : xenothera@izsogood.co